H.C. Wainwright Upgrades Innate Pharma S.A. (IPHA) to Buy Oct 29, 2025 06:24AM
Lucid Capital Markets Starts Innate Pharma S.A. (IPHA) at Buy Oct 23, 2025 07:10AM
Leerink Partners Downgrades Innate Pharma S.A. (IPHA) to Market Perform Sep 18, 2025 03:53AM
BTIG Starts Innate Pharma S.A. (IPHA) at Buy Jul 28, 2025 06:04AM
Innate Pharma (IPHA) Highlights Preclinical Anti-Tumor Efficacy Data of Its Antibody Drug Conjugate IPH4502 Apr 29, 2025 03:00PM


Apr 24, 2025 07:08AM H.C. Wainwright Reiterates Buy Rating on Innate Pharma S.A. (IPHA)
Mar 28, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Innate Pharma S.A. (IPHA)
Jan 17, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Innate Pharma S.A. (IPHA)
Oct 14, 2024 06:03AM Innate Pharma (IPHA) Appoints Jonathan Dickinson as CEO and Board Chair
Sep 13, 2024 06:46AM H.C. Wainwright Reiterates Buy Rating on Innate Pharma S.A. (IPHA)